...
首页> 外文期刊>The Journal of molecular diagnostics: JMD >Assessing heteroplasmic load in Leber's hereditary optic neuropathy mutation 3460G->A/MT-ND1 with a real-time PCR quantitative approach.
【24h】

Assessing heteroplasmic load in Leber's hereditary optic neuropathy mutation 3460G->A/MT-ND1 with a real-time PCR quantitative approach.

机译:使用实时PCR定量方法评估Leber遗传性视神经病变突变3460G-> A / MT-ND1中的异质性负荷。

获取原文
获取原文并翻译 | 示例

摘要

To quantify the amount of the 3460G-->A/ND1 point mutation responsible for Leber's hereditary optic neuropathy, we developed a quantitative real-time polymerase chain reaction method based on the SYBR Green assay and a new approach using the TaqMan assay. Both methods were based on the amplification refractory mutation system, comparing the heteroplasmic load quantified by restriction fragment length polymorphism in 15 Leber's hereditary optic neuropathy family members, with the results obtained using quantitative real-time polymerase chain reaction methods. The comparative evaluation of mitochondrial DNA (mtDNA) heteroplasmy from blood samples showed significant correlation between restriction fragment length polymorphism analysis, real-time SYBR Green assay, and TaqMan assay. We validated the last method by measuring experimental samples composed by a known proportion of cloned plasmids containing either the wild-type or mutant sequence, giving a correlation coefficient of 0.999 (P < 0.0001). The real-time amplification refractory mutation system polymerase chain reaction by TaqMan assay provides a rapid, reliable, sensitive, reproducible, and one-step quantitative method to detect heteroplasmic mutant mtDNA. This method allows the quantitation of a broad range of mutational load (up to 100%, down to 0.01%) on the basis of in vitro calibration, thus rendering the TaqMan assay suitable for the diagnostic analysis of heteroplasmic load in mtDNA-related disorders.
机译:为了量化导致Leber遗传性视神经病变的3460G-> A / ND1点突变的数量,我们开发了一种基于SYBR Green测定的定量实时聚合酶链反应方法和一种使用TaqMan测定的新方法。两种方法均基于扩增难治性突变系统,比较了15个Leber遗传性视神经病变家族成员中通过限制性片段长度多态性定量的异质负载,并使用定量实时聚合酶链反应方法获得了结果。对血液样品中线粒体DNA(mtDNA)异质性的比较评估显示,限制性片段长度多态性分析,实时SYBR Green检测和TaqMan检测之间存在显着相关性。我们通过测量由已知比例的含有野生型或突变序列的克隆质粒组成的实验样品验证了最后一种方法,相关系数为0.999(P <0.0001)。 TaqMan分析法实时扩增难治性突变系统聚合酶链反应提供了一种快速,可靠,灵敏,可重现的一步定量方法来检测异质突变体mtDNA。这种方法可以在体外校准的基础上定量分析各种突变负荷(高达100%,低至0.01%),从而使TaqMan分析适用于mtDNA相关疾病的异质负荷的诊断分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号